Data / Form D filings / ProMIS Neurosciences Inc.
ProMIS Neurosciences Inc.: Form D filings
ProMIS Neurosciences Inc., a biotechnology company in Toronto, Ontario, Canada, filed 30 Form D notices with the SEC between 2009 and 2022. The latest, on October 21, 2022, reports $7.5 million sold of a $10.1 million offering to 23 investors.
Find out what ProMIS Neurosciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SUITE 200, 1920 YONGE STREET, Toronto, Ontario, Canada, M4S 3
- Phone
- (416) 817-6898
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1374339
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 21, 2022 | New notice | $10,066,823 | $7,472,282 | $2,594,541 | 23 | Oct 11, 2022 | sec.gov |
| Sep 9, 2021 | New notice | $24,710,516 | $18,107,000 | $6,603,516 | 34 | Aug 25, 2021 | sec.gov |
| Mar 30, 2021 | New notice | $7,000,000 | $7,000,000 | $0 | 7 | Mar 22, 2021 | sec.gov |
| Nov 16, 2020 | New notice | $147,196 | $62,989 | $84,207 | 3 | Nov 4, 2020 | sec.gov |
| Nov 20, 2019 | New notice | $273,333 | $99,999 | $173,334 | 1 | Nov 15, 2019 | sec.gov |
| Jan 31, 2019 | New notice | $367,893 | $119,409 | $248,484 | 4 | Jan 22, 2019 | sec.gov |
| May 3, 2018 | New notice | $2,845,659 | $1,735,160 | $1,110,499 | 18 | Apr 19, 2018 | sec.gov |
| Sep 11, 2017 | Amendment | $1,126,497 | $704,061 | $422,436 | 15 | Aug 9, 2017 | sec.gov |
| Aug 18, 2017 | New notice | $3,840,000 | $644,061 | $3,195,939 | 13 | Aug 9, 2017 | sec.gov |
| Mar 27, 2017 | New notice | $514,153 | $209,858 | $304,295 | 5 | Feb 10, 2017 | sec.gov |
| Mar 8, 2017 | New notice | $75,517 | $44,694 | $30,823 | 2 | Feb 22, 2017 | sec.gov |
| Nov 22, 2016 | Amendment | $296,635 | $206,310 | $90,325 | 8 | Sep 9, 2016 | sec.gov |
| Sep 22, 2016 | New notice | $282,721 | $206,310 | $76,411 | 7 | Sep 9, 2016 | sec.gov |
| Aug 24, 2016 | New notice | $217,150 | $158,461 | $58,689 | 6 | Aug 10, 2016 | sec.gov |
| Jun 15, 2016 | Amendment | $460,000 | $460,000 | $0 | 5 | Mar 29, 2016 | sec.gov |
| Apr 14, 2016 | New notice | $235,000 | $235,000 | $0 | 5 | Mar 29, 2016 | sec.gov |
| Aug 17, 2015 | New notice | $150,341 | $150,341 | $0 | 7 | Jul 31, 2015 | sec.gov |
| Jul 24, 2015 | New notice | $434,164 | $434,164 | $0 | 6 | Jul 6, 2015 | sec.gov |
| Nov 3, 2014 | New notice | $871,508 | $312,849 | $558,659 | 2 | Oct 20, 2014 | sec.gov |
| Mar 13, 2014 | New notice | $988,713 | $379,233 | $609,480 | 2 | Feb 28, 2014 | sec.gov |
| Feb 11, 2014 | New notice | $656,534 | $251,821 | $404,713 | 1 | Jan 31, 2014 | sec.gov |
| Jan 22, 2014 | New notice | $667,642 | $256,082 | $411,560 | 4 | Jan 14, 2014 | sec.gov |
| May 2, 2013 | New notice | $333,204 | $113,991 | $219,213 | 2 | Apr 19, 2013 | sec.gov |
| Apr 11, 2013 | New notice | $374,790 | $128,218 | $246,572 | 2 | Apr 4, 2013 | sec.gov |
| Mar 5, 2013 | New notice | $103,092 | $39,273 | $63,819 | 1 | Feb 21, 2013 | sec.gov |
| May 29, 2012 | New notice | $40,000 | $20,000 | $20,000 | 1 | May 14, 2012 | sec.gov |
| Mar 16, 2012 | New notice | $81,263 | $25,220 | $56,043 | 1 | Mar 9, 2012 | sec.gov |
| Jan 26, 2012 | New notice | $323,748 | $100,474 | $223,274 | 2 | Jan 17, 2012 | sec.gov |
| Mar 9, 2011 | New notice | $350,000 | $350,000 | $0 | 3 | Feb 28, 2011 | sec.gov |
| Jun 15, 2009 | New notice | $73,646 | $41,626 | $32,020 | 1 | Apr 29, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard T. Gregory | Director | |
| Daniel T. Geffken | Executive Officer | |
| Eugene T. Williams | Director | |
| Josh T. Mandel-Brehm | Director | |
| Larry M. Altstiel | Executive Officer | |
| William K. Wyman | Director | |
| Neil M. Cashman | Executive Officer, Director | |
| Gavin T. Malenfant | Executive Officer | |
| Gail M. Farfel | Executive Officer | |
| Neil K. Warma | Director | |
| Patrick T. Kirwin | Director | |
| Maggie T. Shafmaster | Director |
Every Form D from the week of Oct 17, 2022 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ProMIS Neurosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.